Diagnostic Medical Systems S.A. (EPA:ALDMS)

EPA:ALDMS Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	7.14	5.34	4.76	4.39	4.2
Cash & Short-Term Investments	7.14	5.34	4.76	4.39	4.2
Cash Growth	33.78%	12.26%	8.41%	4.40%	147.24%
Accounts Receivable	11.1	7.48	6.52	5.87	6.79
Inventory	15.68	14.45	16.04	13.05	11.89
Other Current Assets	4.03	3.03	4.37	15.65	7.14
Total Current Assets	37.96	30.3	31.67	28.99	28.06
Net Property, Plant & Equipment	3.96	4.51	5.13	5.49	6.06
Other Intangible Assets	12.1	10.72	9.13	6.72	8.91
Goodwill	8.02	8.02	4.65	0.97	4.04
Long-Term Investments	0.48	0.4	0.55	1.75	3.99
Total Assets	62.52	53.95	51.14	53.89	53.03

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	14.03	10.85	10.41	11.04	9.71
Accrued Expenses	4.21	4.08	4.33	4.05	5.43
Short-Term Debt	5.29	3.88	3.78	1.34	0.07
Current Portion of Long-Term Debt	3.65	4.67	3.09	3.6	5.78
Other Current Liabilities	0.44	0.44	0.42	4.39	0.69
Total Current Liabilities	27.63	23.5	22	20.52	20.99
Long-Term Debt	9.78	11.52	13.2	10.43	10.03
Other Long-Term Liabilities	4.45	4.77	2.2	0.88	0.88
Total Long-Term Liabilities	14.23	16.29	15.4	11.31	10.91
Total Liabilities	41.85	39.79	37.4	31.83	31.9

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	31.61	24.7	20.89	19.1	19.1
Additional Paid-in Capital	1.96	2.34	2.34	1.35	1.35
Accumulated Other Comprehensive Income	-14.27	-11.33	-5.89	2.04	2.16
Retained Earnings	-0.17	-2.88	-4.95	-6.82	-3.88
Total Common Shareholders' Equity	19.14	12.84	12.38	15.66	18.73
Minority Interest	1.53	1.33	1.34	2.51	1.71
Shareholders' Equity	20.66	14.16	13.72	18.17	20.44
Total Liabilities & Equity	62.52	53.95	51.14	53.89	53.03

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	18.73	20.07	20.06	15.37	15.87
Net Cash (Debt)	-11.59	-14.73	-15.3	-10.98	-11.67
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-0.47	-0.65	-0.76	-0.54	-0.72
Book Value	19.14	12.84	12.38	15.66	18.73
Book Value Per Share	0.77	0.56	0.61	0.77	1.16
Tangible Book Value	-0.99	-5.9	-1.4	7.97	5.78
Tangible Book Value Per Share	-0.04	-0.26	-0.07	0.39	0.36

Data Source: Fiscal.ai Last updated: Feb 14, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 2, 2026

Data Sources Report a data error